Street Fight: Citi sees opportunity in Arcturus as COVID data prompts downgrades
Shares of Arcturus Therapeutics (ARCT) are sliding on Tuesday after the company announced updated data for its COVID-19 vaccine candidate, ARCT-021. Arcturus also said... To...